Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
June 26, 2025
Health-Related Quality of Life With Odronextamab Monotherapy for Relapsed/Refractory Follicular Lymphoma in the ELM-2 Study
Benoit Tessoulin, James Harnett, Seok-Goo Cho, et al.
British Journal of Haematology
|
November 30, 2019
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)
Leyre Bento, Antonio Díaz-López, Gilberto Barranco, et al.
Transplantation and Cellular Therapy
|
April 15, 2021
Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers
Silvana Novelli, Leyre Bento, Irene Garcia, et al.
American Journal of Hematology
|
August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
Pierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
European Journal of Haematology
|
December 6, 2019
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era
Antonio Gutierrez, Leyre Bento, Antonio Diaz-Lopez, et al.
Cancers
|
June 10, 2022
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience
Antonio Gutierrez, Leyre Bento, Silvana Novelli, et al.
Bone Marrow Transplantation
|
March 26, 2021
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Leyre Bento, Antonio Gutiérrez, Silvana Novelli, et al.
British Journal of Haematology
|
January 21, 2017
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β<sub>2</sub> -microglobulin yields a more accurate GELTAMO-IPI
Carlos Montalbán, Antonio Díaz-López, Ivan Dlouhy, et al.
Haematologica
|
March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
Alejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
British Journal of Haematology
|
August 8, 2017
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group
Sara Alonso-Álvarez, Laura Magnano, Miguel Alcoceba, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Clinical Lymphoma, Myeloma & Leukemia
|
June 26, 2025
Health-Related Quality of Life With Odronextamab Monotherapy for Relapsed/Refractory Follicular Lymphoma in the ELM-2 Study
Benoit Tessoulin, James Harnett, Seok-Goo Cho, et al.
British Journal of Haematology
|
November 30, 2019
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)
Leyre Bento, Antonio Díaz-López, Gilberto Barranco, et al.
Transplantation and Cellular Therapy
|
April 15, 2021
Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers
Silvana Novelli, Leyre Bento, Irene Garcia, et al.
American Journal of Hematology
|
August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
Pierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
European Journal of Haematology
|
December 6, 2019
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era
Antonio Gutierrez, Leyre Bento, Antonio Diaz-Lopez, et al.
Cancers
|
June 10, 2022
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience
Antonio Gutierrez, Leyre Bento, Silvana Novelli, et al.
Bone Marrow Transplantation
|
March 26, 2021
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Leyre Bento, Antonio Gutiérrez, Silvana Novelli, et al.
British Journal of Haematology
|
January 21, 2017
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β<sub>2</sub> -microglobulin yields a more accurate GELTAMO-IPI
Carlos Montalbán, Antonio Díaz-López, Ivan Dlouhy, et al.
Haematologica
|
March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
Alejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
British Journal of Haematology
|
August 8, 2017
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group
Sara Alonso-Álvarez, Laura Magnano, Miguel Alcoceba, et al.
Page
of 7